ImageneBio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
IMA chart
What traders are saying about $IMA
Latest postsImageneBio, Inc. news
- ImageneBio, Inc. (IMA) Misses Q3 EPS by 11c
StreetInsider ·
- ImageneBio Q3 Results: Loss per share narrows 68.73% YoY
scanx.trade ·
- Form 8K ImageneBio Inc For: 9 November By Investing.com
Investing.com India ·
- ImageneBio Q3 net loss narrows as expenses fall
TradingView ·
- ImageneBio Reports Q3 2026 Results, $15.6 Million Net Loss
TradingView ·
- ImageneBio Reports $15.6 Million Third-Quarter Net Loss
Quiver Quantitative ·
- ImageneBio 3Q 2026: Revenue $0, EPS ($0.91) — 10-Q Summary
TradingView ·
- Quarterly losses narrow at ImageneBio (IMA), which holds $126.6M in cash and securities.
Stock Titan ·
- ImageneBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- ImageneBio Reports Third Quarter 2026 Financial Results
Yahoo Finance ·
- ImageneBio's experimental hair-loss treatment study is on track to start by year-end, with data expected in 2028.
Stock Titan ·
- ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
ImageneBio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $800,000 | $3.5M | $9.2M | $15.6M |
| Net income | -$45.3M | -$36.6M | -$68.2M | -$68.8M |
| Diluted EPS | $-9.64 | $-22.10 | $-1.63 | $-1.90 |
| Total assets (year end) | $153.0M | $15.9M | $192.1M | $172.3M |
| Cash and equivalents (year end) | $94.5M | $12.1M | $119.9M | $59.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ImageneBio, Inc.
- Ticker
- IMA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1835579
- Former names
- Ikena Oncology, Inc.
Frequently asked questions
What exchange is ImageneBio, Inc. listed on?
ImageneBio, Inc. trades on the Nasdaq under the ticker symbol IMA.
What industry is ImageneBio, Inc. in?
ImageneBio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is ImageneBio, Inc. headquartered?
ImageneBio, Inc.'s business address on file with the SEC is in San Diego, CA.
When does ImageneBio, Inc.'s fiscal year end?
ImageneBio, Inc.'s fiscal year ends on December 31.
How much revenue did ImageneBio, Inc. report?
ImageneBio, Inc. reported $800,000 in revenue for calendar year 2025, according to its SEC filings.